Genetics of Response to Proton Pump Inhibitor Therapy: Clinical Implications

Author： Dickson E.J.   Stuart R.C.  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.3, Iss.5, 2003-01, pp. : 303-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gastro-Oesophageal Reflux Disease: Beyond Proton Pump Inhibitor Therapy

By Hershcovici Tiberiu  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2381-2389

Adis International

Access to resources Recommend Favorite

Proton-Pump Inhibitor Therapy in Patients with Gastro-Oesophageal Reflux Disease: Putative Mechanisms of Failure

By Fass Ronnie  

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1521-1530

Adis International

Access to resources Recommend Favorite

Aspirin/clopidogrel/ibuprofen/proton pump inhibitor interaction: Low responsiveness to dual antiplatelet therapy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1430, 2012-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Patient Satisfaction with Switching to Esomeprazole from Existing Proton Pump Inhibitor Therapy for Gastro-Oesophageal Reflux Disease: An Observational, Multicentre Study

By Hoogendoorn Robert J.  

Clinical Drug Investigation, Vol. 29, Iss. 12, 2009-12 ,pp. : 803-810

Adis International

Access to resources Recommend Favorite

CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor

By Furuta Takahisa   Sugimoto Mitsushige   Shirai Naohito   Ishizaki Takashi  

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1199-1210

Future Medicine

Access to resources Recommend Favorite